Search results
Left in limbo: When pharma halts rare disease research
Pharmaceutical Technology· 5 hours agoIt causes a severely compromised immune system, leading to recurrent, severe infections, and...
EAN 2024: VNS and cenobamate – a new therapeutic alliance for drug-resistant epilepsy?
Clinical Trials Arena· 21 hours agoEpilepsy is a neurological disorder characterised by recurrent, unprovoked seizures. Its...